Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Consumer
Moving
Living
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Consumer
Moving
Living
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
KalVista Pharma
(NASDAQ:KALV)
Intraday
$11.99
0
[0.00%]
After-Hours
$11.99
0
[0.00%]
GET A REPORT ON
KALV
SENT RIGHT TO YOUR INBOX
EMAIL*
Submit
Cancel
Get Report
Watch
Perks
Buy
Compare Brokers
$11.99
0
[0.00%]
At close: Mar 18
$11.99
0
[0.00%]
PreMarket: 4:00PM EDT
GET A REPORT ON
KALV
SENT RIGHT TO YOUR INBOX
EMAIL*
Submit
Cancel
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for KalVista Pharma Stock (NASDAQ:KALV)
KalVista Pharma Stock (NASDAQ: KALV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 18, 2024
KalVista Pharmaceuticals Presented Multiple Analyses Of The Relationship Between The Time To Attack Treatment And The Effects Delays In Treatment Have On Clinical Outcomes Of Hereditary Angioedema At The 2024 HAEi Regional Conference Americas
Benzinga Newsdesk
-
22 hours ago
Tuesday, March 12, 2024
HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $24 Price Target
Benzinga Newsdesk
-
6 days ago
KalVista Pharmaceuticals Announced The UK Medicines And Healthcare Products Regulatory Agency Has Awarded The Promising Innovative Medicine Designation For Sebetralstat For On-demand Treatment Of Hereditary Angioedema
Benzinga Newsdesk
-
6 days ago
Monday, March 11, 2024
Needham Maintains Buy on KalVista Pharma, Maintains $35 Price Target
Benzinga Newsdesk
-
Mar 11, 2024, 3:52PM
Recap: KalVista Pharma Q3 Earnings
Benzinga Insights
-
Mar 11, 2024, 9:30AM
KalVista Pharma Q3 EPS $(0.84) Misses $(0.77) Estimate
Benzinga Newsdesk
-
Mar 11, 2024, 6:42AM
Friday, March 08, 2024
KalVista Pharmaceuticals Says It Will Present HAE Attack Journey Data At 2024 HAEi Regional Conference Americas
Benzinga Newsdesk
-
Mar 8, 2024, 6:44AM
Thursday, March 07, 2024
KalVista Pharmaceuticals Announced That Benjamin L. Palleiko, The Current President, CBO And CFO, Has Been Appointed As Chief Executive Officer And A Director Of The Company, Effective Immediately
Benzinga Newsdesk
-
Mar 7, 2024, 6:31AM
Monday, February 26, 2024
KalVista Presents Additional Data On Its Phase 3 KONFIDENT Trial For Sebetralstat
Benzinga Newsdesk
-
Feb 26, 2024, 6:36AM
Tuesday, February 20, 2024
KalVista Says UK MHRA Awarded Innovation Passport For Sebetralstat, An Investigational Novel, Oral Plasma Kallikrein Inhibitor For On-demand Treatment Of Hereditary Angioedema
Benzinga Newsdesk
-
Feb 20, 2024, 6:56AM
Friday, February 16, 2024
KalVista Pharmaceuticals Says It Will Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Benzinga Newsdesk
-
Feb 16, 2024, 6:33AM
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 15, 2024, 8:05AM
KalVista Pharmaceuticals Has Priced The Public Offering Of 7.02M Shares At $15.25/Share And Pre-funded Warrants To Purchase 3.48M Shares, For Gross Proceeds Of Around $160.1M
Benzinga Newsdesk
-
Feb 15, 2024, 6:32AM
Wednesday, February 14, 2024
KalVista Pharmaceuticals Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Benzinga Newsdesk
-
Feb 14, 2024, 4:40PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 14, 2024, 4:31PM
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
-
Feb 14, 2024, 7:49AM
HC Wainwright & Co. Maintains Buy on KalVista Pharma, Raises Price Target to $24
Benzinga Newsdesk
-
Feb 14, 2024, 6:34AM
Tuesday, February 13, 2024
Needham Maintains Buy on KalVista Pharma, Raises Price Target to $35
Benzinga Newsdesk
-
Feb 13, 2024, 2:18PM
What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?
Vandana Singh
-
Feb 13, 2024, 11:02AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 13, 2024, 8:06AM
KalVista Pharmaceuticals Announced Results From The Phase 3 Konfident Trial Demonstrating Statistically And Clinically Significant Efficacy Of Sebetralstat As Oral On-demand Therapy For Hereditary Angioedema
Benzinga Newsdesk
-
Feb 13, 2024, 6:38AM
Friday, February 09, 2024
Insiders Buying Monro And 3 Other Stocks
Avi Kapoor
-
Feb 9, 2024, 8:35AM
Friday, February 02, 2024
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Feb 2, 2024, 8:56AM
Tuesday, January 30, 2024
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
-
Jan 30, 2024, 6:52AM
Monday, January 22, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Jan 22, 2024, 12:35PM
$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Jan 22, 2024, 6:41AM
Wednesday, January 17, 2024
Insiders Buying Dorian LPG And 2 Other Stocks
Avi Kapoor
-
Jan 17, 2024, 6:23AM
Thursday, January 11, 2024
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Avi Kapoor
-
Jan 11, 2024, 6:40AM
Monday, January 08, 2024
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
-
Jan 8, 2024, 7:13AM
Tuesday, January 02, 2024
Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Jan 2, 2024, 9:00AM
Wednesday, December 20, 2023
KalVista Pharma Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
Benzinga Newsdesk
-
Dec 20, 2023, 6:32AM
Thursday, December 07, 2023
KalVista Pharma: Q2 Earnings Insights
Benzinga Insights
-
Dec 7, 2023, 6:45AM
KalVista Pharma Q2 EPS $(0.80) Misses $(0.79) Estimate; Cash, Cash Equivalents And Marketable Securities Were $103.2M
Benzinga Newsdesk
-
Dec 7, 2023, 6:33AM
Monday, November 13, 2023
KalVista Sas Achieved Targeted Number Of On-Treatment Attacks Required To Complete Phase 3 KONFIDENT Trial; Topline Data Expected Early 2024
Benzinga Newsdesk
-
Nov 13, 2023, 6:32AM
Friday, September 29, 2023
KalVista Pharma Board Member Awarded $94K Worth of Stock Options
Benzinga Insights
-
Sep 29, 2023, 11:00AM
KalVista Pharma Director Awarded $94K Worth of Stock Options
Benzinga Insights
-
Sep 29, 2023, 11:00AM
Director at KalVista Pharma Acquires Company Stock Options Worth 10,000 Shares
Benzinga Insights
-
Sep 29, 2023, 11:00AM
Thursday, September 14, 2023
Director at KalVista Pharma Exercises Options Worth $183K
Benzinga Insights
-
Sep 14, 2023, 11:02AM
Friday, September 08, 2023
HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $16 Price Target
Benzinga Newsdesk
-
Sep 8, 2023, 7:09AM
Thursday, September 07, 2023
KalVista Pharma Q1 EPS $(0.74) Beats $(0.86) Estimate; Cash Position Of $123.3M
Benzinga Newsdesk
-
Sep 7, 2023, 6:31AM
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on KalVista Pharma, Maintains $20 Price Target
Benzinga Newsdesk
-
Aug 22, 2023, 9:52AM
Wednesday, August 02, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Aug 2, 2023, 9:06AM
Monday, July 10, 2023
HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $16 Price Target
Benzinga Newsdesk
-
Jul 10, 2023, 6:19AM
Friday, July 07, 2023
KalVista Pharmaceuticals shares are trading higher after the company issued better-than-expected Q4 EPS.
Benzinga Newsdesk
-
Jul 7, 2023, 10:38AM
Recap: KalVista Pharma Q4 Earnings
Benzinga Insights
-
Jul 7, 2023, 7:10AM
KalVista Appointed Brian J.G. Pereira As Chairman Of Board of Directors, Promoted Benjamin Palleiko To The Role Of President Of The Company
Benzinga Newsdesk
-
Jul 7, 2023, 6:37AM
KalVista Pharma Q4 EPS $(0.77) Beats $(0.89) Estimate; Cash, Cash Equivalents & Marketable Securities Of $149.4M Providing Runway Into 2025
Benzinga Newsdesk
-
Jul 7, 2023, 6:33AM
Monday, June 12, 2023
Kalvista Pharmaceuticals Presented Data On Sebetralstat For Hereditary Angioedema; Sebetralstat Pharmacokinetic And Pharmacodynamic Data Support Globalization Of The KONFIDENT Phase 3 Trial And Use In Short-term Prophylaxis
Benzinga Newsdesk
-
Jun 12, 2023, 6:37AM
Tuesday, May 23, 2023
President at KalVista Pharma Acquires Company Stock Options Worth 40,000 Shares
Benzinga Insights
-
May 23, 2023, 11:01AM
Friday, April 21, 2023
Analyst Expectations for KalVista Pharma's Future
Benzinga Insights
-
Apr 21, 2023, 11:01AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch